Brenda Cooperstone
Director/Board Member at SENTI BIOSCIENCES, INC.
Net worth: - $ as of 30/03/2024
Profile
Brenda Cooperstone is currently the Director at Senti Sub I, Inc., the Independent Director at Lexeo Therapeutics, Inc., the Independent Director at Senti Biosciences, Inc., and the Independent Director at Gandeeva Therapeutics, Inc. Previously, she worked at Pfizer Inc. as the Chief Development Officer & Senior Vice President from 2017 to 2022.
Dr. Cooperstone holds a doctorate degree from McGill University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SENTI BIOSCIENCES, INC.
-.--% | 15/06/2023 | 0 ( -.--% ) | - $ | 30/03/2024 |
LEXEO THERAPEUTICS, INC.
-.--% | 02/11/2023 | 0 ( -.--% ) | - $ | 30/03/2024 |
Brenda Cooperstone active positions
| Companies | Position | Start |
|---|---|---|
| SENTI BIOSCIENCES, INC. | Director/Board Member | 30/09/2019 |
| LEXEO THERAPEUTICS, INC. | Director/Board Member | 31/07/2023 |
Senti Sub I, Inc.
 Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Director/Board Member | 30/09/2019 |
Gandeeva Therapeutics, Inc.
 Gandeeva Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Gandeeva Therapeutics, Inc. is a Canadian company that specializes in drug discovery using a unique approach to develop precision medicines. The company is based in Vancouver, Canada and was founded by Sriram Subramaniam, who has been the CEO since incorporation. The company's focus is on understanding the language by which proteins communicate in vivo, which is fundamental to deciphering biology. The company's discovery process involves identifying the optimal protein-protein interactions and altering protein structures to develop drugs that can treat various diseases. | Director/Board Member | 22/01/2023 |
Former positions of Brenda Cooperstone
| Companies | Position | End |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 30/11/2022 |
Training of Brenda Cooperstone
| McGill University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| LEXEO THERAPEUTICS, INC. | Health Technology |
| SENTI BIOSCIENCES, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Health Technology |
Gandeeva Therapeutics, Inc.
Gandeeva Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Gandeeva Therapeutics, Inc. is a Canadian company that specializes in drug discovery using a unique approach to develop precision medicines. The company is based in Vancouver, Canada and was founded by Sriram Subramaniam, who has been the CEO since incorporation. The company's focus is on understanding the language by which proteins communicate in vivo, which is fundamental to deciphering biology. The company's discovery process involves identifying the optimal protein-protein interactions and altering protein structures to develop drugs that can treat various diseases. | Commercial Services |
- Stock Market
- Insiders
- Brenda Cooperstone
